NCT00097968View on ClinicalTrials.gov

Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2004

Primary Completion Date

April 30, 2005

Conditions
Graft Rejection
Interventions
DRUG

everolimus

Trial Locations (6)

10032

Columbia Presbyterian Medical Center, New York

19140

Temple University Hospital, Philadelphia

37203

Midstate Cardiology, Nashville

44195

Cleveland Clinic Foundation, Cleveland

55455

University of Minnesota, Fairfield University Hospital, Minneapolis

90095

UCLA Medical Center, Los Angeles

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY